Literature DB >> 6182098

Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation.

R Hällgren, A Terént, P Venge.   

Abstract

The CSF levels of lactoferrin, lysozyme, and beta 2-microglobulin (beta 2 mu) were measured in patients with evident, probable, or possible inflammatory CNS reactions and compared to those found in neurologically apparently healthy patients. Patients with viral CNS infections had significantly raised beta 2 mu and lysozyme levels but normal lactoferrin levels, indicating a local activation of lymphocytes and monocytes but not of granulocytes. Patients with bacterial CNS infections had significantly raised levels of all three cell markers, but the increase of lysozyme and lactoferrin was relatively more pronounced than that of beta 2 mu, indicating that the inflammatory response to bacterial agents is dominated by monocytes and granulocytes. Patients with primary or secondary malignant brain tumors were characterized by a moderate increase of beta 2 mu and a considerable increase in both lysozyme and lactoferrin, i.e., the same protein pattern as observed in bacterial CNS infection. The lysozyme levels were moderately increased in half the patients with benign cerebral tumors while the levels of beta 2 mu and lactoferrin were normal, indicating that benign and malignant brain tumors induce different local inflammatory CNS reactions. Half the patients with pituitary gland adenoma had elevated beta 2 mu and lysozyme levels but normal lactoferrin levels, suggesting that immunological mechanisms are associated with the adenoma development. Patients with MS had moderately but significantly raised CSF levels of beta 2 mu and lysozyme and a third of them also had raised levels of lactoferrin, a protein pattern suggesting a low-active inflammatory process in CNS involving mononuclears and granulocytes. A similar protein pattern was found in Guillain-Barré syndrome. In cerebrosarcoidosis we noted considerably increased lysozyme and beta 2 mu but normal lactoferrin levels, consistent with the idea that the sarcoid granuloma mass is dominated by monocytic inflammatory cells. The data obtained indicate a clinical value of lactoferrin, lysozyme, and beta 2 mu as differential indices of inflammatory cell reactions taking place in various CNS processes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182098     DOI: 10.1007/bf00916410

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  33 in total

1.  Protein size and cerebrospinal fluid composition.

Authors:  K Felgenhauer
Journal:  Klin Wochenschr       Date:  1974-12-15

2.  Character of azurophil and specific granules purified from human polymorphonuclear leukocytes.

Authors:  J K Spitznagel; F G Dalldorf; M S Leffell; J D Folds; I R Welsh; M H Cooney; L E Martin
Journal:  Lab Invest       Date:  1974-06       Impact factor: 5.662

3.  Tissue distribution of lysozyme in man.

Authors:  M Klockars; S Reitamo
Journal:  J Histochem Cytochem       Date:  1975-12       Impact factor: 2.479

4.  Intracellular and extracellular degranulation of human polymorphonuclear azurophil and specific granules induced by immune complexes.

Authors:  M S Leffell; J K Spitznagel
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

5.  Experiemental and clinical studies on muramidase (lysozyme). I. Muramidase activity of normal human blood cells and inflammatory exudates.

Authors:  H J Senn; B Chu; J O'Malley; J F Holland
Journal:  Acta Haematol       Date:  1970       Impact factor: 2.195

6.  Serial measurement of beta2 microglobulin, acute phase reactant proteins and the ESR in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.

Authors:  E H Cooper; R Bunning; S Illingworth; B Späti; J A Child
Journal:  Biomedicine       Date:  1978-07

7.  Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis.

Authors:  N Talal; H M Grey; N Zvaifler; J P Michalski; T E Daniels
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

8.  Cerebrospinal fluid lysozyme activity in patients with central nervous system tumours.

Authors:  N Di Lorenzo; L Palma; L Ferrante
Journal:  Neurochirurgia (Stuttg)       Date:  1977-01

9.  The beta 2-microglobulin content of the cerebrospinal fluid in neurological disease.

Authors:  J J Starmans; J Vos; H J van der Helm
Journal:  J Neurol Sci       Date:  1977-08       Impact factor: 3.181

Review 10.  Multiple sclerosis: evidence for immunopathogenesis.

Authors:  R P Lisak
Journal:  Neurology       Date:  1980-07       Impact factor: 9.910

View more
  8 in total

1.  Neurosarcoidosis presenting in the pituitary gland with normal endocrine studies.

Authors:  J E Arle; A R Judkins; M J Kotapka
Journal:  Skull Base Surg       Date:  1999

2.  Increased beta 2-microglobulin in CSF of multiple sclerosis.

Authors:  J C Alvarez-Cermeño; L M Villar; G Roy; A Ferreira; A Bootello; A Gimeno; P González-Porqué
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

3.  Bayesian inference for parameter estimation in lactoferrin-mediated iron transport across blood-brain barrier.

Authors:  Aminul Islam Khan; Jin Liu; Prashanta Dutta
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-11-01       Impact factor: 3.770

4.  Beta2-microglobulin concentrations in cerebrospinal fluid correlate with neuroimaging findings in newborns with symptomatic congenital cytomegalovirus infection.

Authors:  Ana Alarcon; Alfredo Garcia-Alix; Fernando Cabañas; Angel Hernanz; Dora Pascual-Salcedo; Ana Martin-Ancel; Marta Cabrera; Alfredo Tagarro; Jose Quero
Journal:  Eur J Pediatr       Date:  2006-05-12       Impact factor: 3.183

5.  Serum beta 2-microglobulin and C reactive protein concentrations in viral infections.

Authors:  E H Cooper; M A Forbes; M H Hambling
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

6.  Cerebrospinal fluid beta 2-microglobulin in neonates with central nervous system infections.

Authors:  A García-Alix; A Martín-Ancel; M T Ramos; S Salas; A Pellicer; F Cabañas; J Quero
Journal:  Eur J Pediatr       Date:  1995-04       Impact factor: 3.183

7.  Elevated cerebrospinal fluid levels of beta-2-microglobulin in patients with Guillain-Barré syndrome and their correlations with clinical features.

Authors:  Ming-Qi Liu; Jing Wang; Chen-Na Huang; Yuan Qi; Lin-Jie Zhang; Ming Yi; Sheng-Hui Chang; Li-Sha Sun; Li Yang
Journal:  Neurol Sci       Date:  2021-02-17       Impact factor: 3.307

8.  Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome.

Authors:  Lourdes Mateos-Hernández; Margarita Villar; Ernesto Doncel-Pérez; Marco Trevisan-Herraz; Ángel García-Forcada; Francisco Romero Ganuza; Jesús Vázquez; José de la Fuente
Journal:  Oncotarget       Date:  2016-11-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.